Your browser doesn't support javascript.
loading
Specific, targetable interactions with the microenvironment influence imatinib-resistant chronic myeloid leukemia.
Kumar, Rahul; Pereira, Raquel S; Zanetti, Costanza; Minciacchi, Valentina R; Merten, Maximilian; Meister, Melanie; Niemann, Julian; Dietz, Marina S; Rüssel, Nina; Schnütgen, Frank; Tamai, Minori; Akahane, Koshi; Inukai, Takeshi; Oellerich, Thomas; Kvasnicka, Hans Michael; Pfeifer, Heike; Nicolini, Franck E; Heilemann, Mike; Van Etten, Richard A; Krause, Daniela S.
Afiliación
  • Kumar R; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, 60596, Frankfurt am Main, Germany.
  • Pereira RS; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, 60596, Frankfurt am Main, Germany.
  • Zanetti C; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, 60596, Frankfurt am Main, Germany.
  • Minciacchi VR; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, 60596, Frankfurt am Main, Germany.
  • Merten M; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, 60596, Frankfurt am Main, Germany.
  • Meister M; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, 60596, Frankfurt am Main, Germany.
  • Niemann J; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, 60596, Frankfurt am Main, Germany.
  • Dietz MS; Institute for Physical and Theoretical Chemistry, Goethe-University Frankfurt, Frankfurt am Main, Germany.
  • Rüssel N; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, 60596, Frankfurt am Main, Germany.
  • Schnütgen F; Department of Internal Medicine, Hematology/Oncology, Goethe University, Frankfurt am Main, Germany.
  • Tamai M; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.
  • Akahane K; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
  • Inukai T; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
  • Oellerich T; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
  • Kvasnicka HM; Department of Internal Medicine, Hematology/Oncology, Goethe University, Frankfurt am Main, Germany.
  • Pfeifer H; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.
  • Nicolini FE; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Heilemann M; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Van Etten RA; Senckenberg Institute of Pathology, Goethe University Frankfurt, 60590, Frankfurt am Main, Germany.
  • Krause DS; Department of Internal Medicine, Hematology/Oncology, Goethe University, Frankfurt am Main, Germany.
Leukemia ; 34(8): 2087-2101, 2020 08.
Article en En | MEDLINE | ID: mdl-32439895
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Mesilato de Imatinib Límite: Animals / Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Mesilato de Imatinib Límite: Animals / Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido